Search results
AbbVie's Upadacitinib Shows Clinical Response In Crohn's Disease Maintenance Study At One Year
Benzinga via Yahoo Finance· 2 years agoAbbVie Inc (NYSE: ABBV) announced topline results from U-ENDURE Phase 3 maintenance study evaluating...
EMA's CHMP Recommends AbbVie's Upadacitinib For Ulcerative Colitis
Benzinga via Yahoo Finance· 2 years agoThe European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 7 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 11 months agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...
AbbVie's (ABBV) Rinvoq Meets Crohn's Disease Study Goals
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) Rinvoq achieves statistical significance with its co-primary endpoints of clinical...
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV announced that the European Medicines Agency’s Committee for Medicinal Products for...
AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV submitted a new drug application (“NDA”) for ABBV-951 (foscarbidopa/foslevodopa)...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 2 weeks agoThis week, J&J JNJ began the first-quarter 2024 earnings season for the pharma space with mixed...
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – March 27, 2023 – Zacks.com announces the list of stocks featured...
A new ‘cure for eczema’ pill has been signed off – but who is allowed to take it?
Cosmo via Yahoo News· 2 years agoThe NHS has given new drugs - said to clear up eczema in a week - the go ahead. But who can take the...